Radar · Biopharma Outsourcing in Hyderabad
Best Biopharma Outsourcing Companies in Hyderabad, India
The 259 best Biopharma Outsourcing companies in Hyderabad, India in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Gland Pharma.
By Riya SenguptaFinancials
259companies tracked
$699Mdisclosed funding
0unicorns
29have raised
FLIAR INTELLIGENCE · BIOPHARMA OUTSOURCING × HYDERABAD
Our analysis of 50 Biopharma Outsourcing companies
$3.9b in tracked funding; 60% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2021.
50companies analysed
60%cloud-native stacks
2021funding peak (by rounds)
2002median founding year
55median Fliar Index™
860kcombined LinkedIn audience
66%of audience held by top 3
8companies hiring publicly (12 mo)
Ranked: Best Biopharma Outsourcing companies in Hyderabad
| # | Company | Revenue | Revenue YoY | Disclosed funding | Employees | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Gland Pharma Manufacturer of generic injectable drug 57Market top 23%Fin. health top 27%Moat top 29%Funding top 30% All 11 signals ▾Markettop 23% Fin. healthtop 27% Moattop 29% Fundingtop 30% Talenttop 38% Newstop 42% Patentsbottom 48% Globalbottom 42% Innovationbottom 40% Techbottom 36% Growthbottom 35% Market: 4,321 employees (top 2% of Biopharma Outsourcing) · Revenue ~$690M Fin. health: Revenue ~$690M (FY2022) · Net margin 17.8% rank vs industry peers · Fliar Intelligence Index 57/100 | $690M FY2025 | — | $209M | 4,321 4,321 → 3,968 (-8%) · sector median +17% | Ravi Penmetsa Co-Founder | 14 patents Formulation and manufacturing processes for injectable drugs and stable drug derivatives | 1 award |
| 2 | Aragen Provider of drug discovery, clinical development, manufacturing, and other services for small molecules 82Fin. health top 23%Market top 26%Funding top 34%Moat top 34% All 9 signals ▾Fin. healthtop 23% Markettop 26% Fundingtop 34% Moattop 34% Techtop 38% Talenttop 39% Growthbottom 48% Globalbottom 45% Newsbottom 30% Fin. health: Revenue ~$221M (FY2022) · Net margin 15.1% Market: 4,049 employees (top 5% of Biopharma Outsourcing) · Revenue ~$221M rank vs industry peers · Fliar Intelligence Index 82/100 | $221M FY2025 | +12% | $25M | 4,049 4,049 → 4,622 (+14%) · sector median +17% | Aniel Khubchandani CEO - Development and Manufacturing Solution | — | 1 job opening |
| 3 | Sai Life Sciences Provider of drug discovery, developing, and manufacturing of complex small molecules 72Moat top 20%Funding top 22%Market top 28%Fin. health top 36% All 9 signals ▾Moattop 20% Fundingtop 22% Markettop 28% Fin. healthtop 36% Talenttop 38% Techtop 43% Growthtop 49% Newsbottom 49% Globalbottom 39% Moat: Top 1% by revenue among 1485 tracked Biopharma Outsourcing companies · Editorial + unicorn rating 8/10 Funding: Raised $112M across 10 rounds · 10 rounds over 20 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 72/100 | $205M FY2025 | +16% | $112M | 2,948 2,948 → 4,299 (+46%) · sector median +17% | Krishna Kanumuri CEO & MD | — | 1 job opening |
| 4 | AnaCipher CRO CRO focused on bioanalytical services to biopharma sector | $198M FY2025 | -9% | — | 914 | — | — | — |
| 5 | Viyash CDMO focused on manufacturing of APIs & intermediates 57Moat top 34%Market top 36%Funding top 36%Fin. health top 48% All 9 signals ▾Moattop 34% Markettop 36% Fundingtop 36% Fin. healthtop 48% Talentbottom 49% Techbottom 48% Growthbottom 47% Globalbottom 37% Newsbottom 31% Moat: Top 1% by revenue among 1485 tracked Biopharma Outsourcing companies · Editorial + unicorn rating 1/10 Market: 264 employees (top 42% of Biopharma Outsourcing) · Revenue ~$175M rank vs industry peers · Fliar Intelligence Index 57/100 | $175M FY2025 | +9% | $120M | 264 264 → 332 (+26%) · sector median +17% | Haribabu Bodepudi Co-Founder & CEO | — | — |
| 6 | Lee Pharma Pharmaceutical company focused on providing APIs, intermediates, and finished dosage forms | $110M FY2025 | +2% | $6M | 175 | Venkata Alla Founder & Managing Director | 47 patents Solid-state forms and manufacturing processes for small-molecule drug compounds. | — |
| 7 | Optimus Manufacturer of APIs, intermediates, and finished formulations | $91M FY2025 | +8% | $11M | 75 | Santhosh Mahil CEO & Managing Director | — | — |
| 8 | Ra Chem Pharma Contract developer and manufacturer of API & formulations | $84M FY2021 | — | $4M | 3,000 | Ravi K Yerra Co-Founder & Executive Director | 12 patents One‑pot heterocyclic intermediate synthesis for zilpaterol and improved propiomazine production | — |
| 9 | Biophore Development and manufacturing of niche pharmaceutical products for the generic industry | $54M FY2025 | — | $3M | 638 | Jagadeesh Rangisetty Co-Founder & CEO | — | — |
| 10 | Aizant Company offering contract development services for small molecules | $36M FY2025 | +7% | $17M | 762 762 → 987 (+30%) · sector median +17% | Padmaja Rudraraju Co-Founder | — | — |
| 11 | A R Life Sciences Contract manufacturer of APIs and drug Intermediates | $27M FY2025 | +9% | — | 75 | K Reddy Founder | 2,655 patents Pharmaceutical heterocyclic drug compounds and advanced oral/implantable formulations | — |
| 12 | Aktinos Pharma Contract manufacturer of API intermediates | $25M FY2024 | +18% | — | 175 | Murali Madala Managing Director | — | — |
| 13 | Chemvedals Contract research, development and manufacturing services for small moleculeS | $15M FY2025 | +9% | $3M | 143 | — | — | 1 expansion |
| 14 | Vivimed Labs Manufacturer of APIs, formulations and specialty chemicals 13Funding top 38%Moat top 38%Tech bottom 43%Market bottom 40% All 8 signals ▾Fundingtop 38% Moattop 38% Techbottom 43% Marketbottom 40% Globalbottom 39% Newsbottom 36% Fin. healthbottom 23% Growthbottom 19% Funding: Raised $100M across 5 rounds · 5 rounds over 15 yrs (0.3/yr) Moat: Top 17% by revenue among 1485 tracked Biopharma Outsourcing companies · Editorial + unicorn rating 1/10 rank vs industry peers · Fliar Intelligence Index 13/100 | $14M FY2025 | -24% | $100M | 58 | — | — | 8 job openings |
| 15 | LAXAI Provider of drug discovery & development services | $14M FY2025 | -35% | — | 427 427 → 354 (-17%) · sector median +17% | — | — | 6 job openings |
| 16 | Alcedo Pharmachem Pharmaceutical company specializing in excipients for drug coats and binders | $11M FY2025 | +26% | — | 104 | Sumanth Mettu CEO | — | — |
| 17 | Analys Lab Provider of validation and contract analytical testing laboratory services | $10M FY2025 | +32% | — | 119 | — | — | — |
| 18 | VKT Pharma CDMO focused on manufacturing of drugs formulations | $9M FY2021 | +70% | $1M | 507 | James Thamil Group CEO | — | — |
| 19 | Glochem Industries CDMO focused on manufacturing of API products for biopharma sector | $7M FY2023 | -62% | $1M | 204 204 → 245 (+20%) · sector median +17% | Kattamuri Subbarao Founder & Managing Director | — | — |
| 20 | Yapanbio Contract manufacturer of bio-therapeutics and vaccines 50Growth top 30%Talent top 38%Moat top 46%Fin. health top 50% All 9 signals ▾Growthtop 30% Talenttop 38% Moattop 46% Fin. healthtop 50% Fundingbottom 46% Techbottom 46% Marketbottom 37% Globalbottom 32% Newsbottom 22% Growth: Headcount 46 → 67 (+46%) across vintages · Web rank 50,000,000 → 10,000,000 YoY Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 50/100 | $7M FY2025 | — | $13M | 67 67 → 51 (-24%) · sector median +17% | Nirav Desai Co-Founder | — | — |
| 21 | Sapala Organics Research organization specializing in custom synthesis of various organic compounds | $6M FY2025 | -28% | $735K | 205 | Masami Nakane CEO | — | — |
| 22 | Aparna Pharmaceuticals CDMO focused on manufacturing API intermediates | $6M FY2023 | — | $674K | 328 | Rakesh Reddy Founder & Director | — | — |
| 23 | Amara Labs Manufacturer of active pharmaceutical ingredients, bulk drug intermediates, and new molecules | $6M FY2021 | +173% | — | — | Narendra Suryadevara Founder & Managing Director | — | — |
| 24 | AAP Pharma Technologies Contract research organization providing custom synthesis and contract manufacturing services to… | $5M FY2024 | — | — | 77 | Sreenu Guntha Founder & Director | — | — |
| 25 | Accrete Pharma Offers contract manufacturing services in bulk drugs and intermediates | $5M FY2025 | +19% | — | 51 | DN Mohan Reddy Founder & Director | — | — |
| 26 | Discovery Labs Manufacturer of APIs and pharmaceutical ingredients | $5M FY2025 | +99% | $245K | 34 | Prashanth Manne CEO | — | — |
| 27 | Anthea Pharma Provider of formulation development, marketing, quality management, and regulatory support services | $3M FY2025 | +516% | — | 460 | — | — | — |
| 28 | Anwita Drugs Pharmaceutical company with capabilities in research, manufacturing, and marketing across multiple… | $2M FY2025 | -11% | — | — | — | — | — |
| 29 | Incozen Therapeutics Discovery, preclinical and development services for drug candidates | $1M FY2025 | -21% | — | 22 | Swaroop Vakkalanka Founder & CEO and MD | 116 patents Selective PI3Kδ/γ, SIK3, PARP7, and POLθ small‑molecule inhibitors for solid‑tumor cancer therapy | — |
| 30 | Aganitha Provider of AI-powered drug discovery and development solutions | $1M FY2025 | +27% | $15K | 74 74 → 127 (+72%) · sector median +17% | Ramarao Kanneganti Co-Founder & CTO | — | 1 launch |
| 31 | airis PHARMA Manufacturer of tablets, capsules, syrup, and injectables | $1M FY2024 | — | — | 46 | Ajoy Koppolu CEO & MD | — | — |
| 32 | Apogen CDMO focused in the development of novel pellet based intermediates for generic drug formulations | $1M FY2025 | -35% | — | — | — | — | — |
| 33 | GenePowerX Biotechnology company offering genetic testing and analysis services | $815K FY2025 | +71% | $500K | 37 37 → 30 (-19%) · sector median +17% | Hima Challa Co-Founder | — | 1 launch |
| 34 | Adept Pharma and Bioscience Excellence Developer and manufacturer small molecules | $801K FY2025 | — | — | — | Naga Pasam CEO | — | — |
| 35 | Srigen Life Sciences Provider of API intermediates developing services for the pharmaceutical sector | $568K FY2024 | +71% | $158K | — | — | — | — |
| 36 | Anax Laboratories Provider of integrated development and discovery services for research chemicals | $518K FY2025 | — | — | — | Narendra Revanuri CEO | — | — |
| 37 | Acubiosys Research and development based company focused on the development of drugs | $242K FY2025 | +41% | — | — | Srinivas Maddi Founder & CEO | 2 patents Herbal‑metformin combination therapeutics for diabetes and metabolic syndrome treatment | — |
| 38 | Amigos Molecular Solutions Provider of contract research & API products manufacturing services | $60K FY2025 | +256% | — | — | — | — | — |
| 39 | Centella Technology platform that provides end-to-end scientific research solutions to the scientific community | $4K FY2025 | -24% | $280K | — | Poornachandra Co-Founder | — | — |
| 40 | Aryastha Contract research and development offering drugs development services 14Growth top 45%Talent top 45%Tech top 46%Funding bottom 34% All 8 signals ▾Growthtop 45% Talenttop 45% Techtop 46% Fundingbottom 34% Globalbottom 29% Moatbottom 27% Marketbottom 17% Fin. healthbottom 10% Talent: 2 named leaders on record rank vs industry peers · Fliar Intelligence Index 14/100 | — | — | $2M | — | Raghava Kethri Co-Founder & CEO | — | 7 job openings |
| 41 | Neuland Manufacturer of active pharmaceutical ingredients (APIs) and peptides 82Fin. health top 15%Innovation top 20%Product top 21%Market top 30% All 11 signals ▾Fin. healthtop 15% Innovationtop 20% Producttop 21% Markettop 30% Techtop 32% Moattop 34% Fundingtop 42% Newstop 45% Growthtop 46% Talentbottom 49% Globalbottom 48% Fin. health: Revenue ~$216M (FY2018) · Net margin 17.6% Innovation: 7 product lines rank vs industry peers · Fliar Intelligence Index 82/100 | — | — | $27M | 1,865 1,865 → 2,007 (+8%) · sector median +17% | Davuluri Rao Vice Chairman of the Board and CEO | — | 1 launch · 1 partnership |
| 42 | Jupiter Bioscience CDMO focused on manufacturing of peptides | — | — | $24M | — | Narayanan Srinivasan CEO | — | — |
| 43 | Vimta Contract research organization offering range of services | — | — | $17M | 1,427 1,427 → 1,819 (+27%) · sector median +17% | — | — | — |
| 44 | Pranaya Group CDMO focused on manufacturing of APIs | — | — | $898K | — | Sridhar Sanagala Managing Director | — | — |
Top 12 Biopharma Outsourcing companies in Hyderabad
#1
Series B · Hyderabad, Telangana · founded 2001 · 4049 employees$25.4Mraised▾
Series B · Hyderabad, Telangana · founded 2001 · 4049 employees
Provider of drug discovery, clinical development, manufacturing, and other services for small molecules
Fliar Intelligence Index™ 82how this company ranks against its industry peers
Fin. health
top 23%Market
top 26%Funding
top 34%Moat
top 34%Tech
top 38%Talent
top 39%Fin. health: Revenue ~$221M (FY2022) · Net margin 15.1% · Revenue +12% YoY
Market: 4,049 employees (top 5% of Biopharma Outsourcing) · Revenue ~$221M · ~1% of tracked Biopharma Outsourcing revenue (1485 cos, FY2025)
Funding: Raised $25.4M across 3 rounds · 3 rounds over 19 yrs (0.2/yr) · Last round PE (Aug 2025)
Audience (LinkedIn): 250k LinkedIn followers — 29.1% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Discovery Solutions
Funding rounds
- Aug 2025PE$36M
- Jan 2025PE$100M
- May 2021Series B—
- Nov 2007Series B$25.4M
Founders & team
Investors
Sequoia Capital, Goldman Sachs, Quadria Capital, Leo Investment Holdings, Avendus, Broadoak Capital Partners
Tech stack
AosAutoptimizeBootstrapCloudflareCloudflare Bot ManagementContact Form 7
#2
Public · Hyderabad, Telangana · founded 1999 · 2948 employees$112.2Mraised▾
Public · Hyderabad, Telangana · founded 1999 · 2948 employees
Provider of drug discovery, developing, and manufacturing of complex small molecules. Its offerings include synthetic and medicinal chemistry services, pre-clinical toxicology, and DMPK studies. Its CMC services in lyophilization, liposome & formulation development segment includes pre-formulation, analytical development, and stability studies.
Fliar Intelligence Index™ 72how this company ranks against its industry peers
Moat
top 20%Funding
top 22%Market
top 28%Fin. health
top 36%Talent
top 38%Tech
top 43%Moat: Top 1% by revenue among 1485 tracked Biopharma Outsourcing companies · Editorial + unicorn rating 8/10 · Soonicorn
Funding: Raised $112M across 10 rounds · 10 rounds over 20 yrs (0.5/yr) · Last round Angel (Jul 2024)
Market: 2,948 employees (top 6% of Biopharma Outsourcing) · Revenue ~$205M · Top 1% by revenue among 1485 tracked Biopharma Outsourcing peers
Audience (LinkedIn): 207k LinkedIn followers — 24.0% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Scientific Team Leaders, Group Leaders
Funding rounds
- Jul 2024Angel$1.1M
- Jul 2022Angel$99.5K
- Jul 2021Angel$106.9K
- Jul 2020Angel$106.1K
Founders & team
Investors
HBM Partners, Beta Tc Holdings, Tata Capital, Advantium, HBM Healthcare Investments, Sequoia Capital
Tech stack
Amazon Web ServicesApache Http ServerAws Certificate ManagerCdnjsCloudflareCloudflare Bot Management
#3
Seed · Hyderabad, Telangana · founded 2019 · 264 employees$120Mraised▾
Seed · Hyderabad, Telangana · founded 2019 · 264 employees
CDMO focused on manufacturing of APIs & intermediates
Fliar Intelligence Index™ 57how this company ranks against its industry peers
Moat
top 34%Market
top 36%Funding
top 36%Fin. health
top 48%Talent
bottom 49%Tech
bottom 48%Moat: Top 1% by revenue among 1485 tracked Biopharma Outsourcing companies · Editorial + unicorn rating 1/10 · 9 curated direct competitors tracked
Market: 264 employees (top 42% of Biopharma Outsourcing) · Revenue ~$175M · Top 1% by revenue among 1485 tracked Biopharma Outsourcing peers
Funding: Raised $120M across 2 rounds · 2 rounds over 6 yrs (0.3/yr) · Last round Angel (Jul 2021)
Audience (LinkedIn): 4k LinkedIn followers
Funding rounds
- Jul 2021Angel$112M
- Mar 2020Angel$8.1M
Founders & team
Investors
The Carlyle Group, Pharminn Enterprise, Thecarlylegroup.fr
Tech stack
Apache Http ServerGodaddyHstsMicrosoft 365Open GraphPwa
#4
Public · Hyderabad, Telangana · founded 1988 · 58 employees$100.2Mraised▾
Public · Hyderabad, Telangana · founded 1988 · 58 employees
Vivimed Labs is a global supplier of speciality chemicals and pharmaceuticals and a manufacturer of active pharmaceutical ingredients, formulations and active ingredients for Home and Personal Care, hair dyes, imaging chemicals and photochromics. Vivimed Labs has a customer base spread across 50 countries. The company is engaged in the manufacture of Cosmetics, Pharmaceuticals, Nutraceuticals, Photochromics, Natural Actives, Colors and Dyes. Since 2005, Vivimed has expanded rapidly with the acquisition of companies like James Robinson, UK, and Har-Met International Inc. The company currently has 5 manufacturing plants located in India along with R&D labs in the UK and India.
Fliar Intelligence Index™ 13how this company ranks against its industry peers
Funding
top 38%Moat
top 38%Tech
bottom 43%Market
bottom 40%Global
bottom 39%News
bottom 36%Funding: Raised $100M across 5 rounds · 5 rounds over 15 yrs (0.3/yr) · Last round Post IPO (Jan 2018)
Moat: Top 17% by revenue among 1485 tracked Biopharma Outsourcing companies · Editorial + unicorn rating 1/10
Tech: 24 technologies across 2/8 capability areas · Devops: Nginx · Security: Http/3, Sucuri
Audience (LinkedIn): 8k LinkedIn followers
Hiring (LinkedIn): 8 hiring posts in 12 mo (public) · momentum +8 · hiring: Production Department, Packing Line
Funding rounds
- Jan 2018Post IPO$7.5M
- Sep 2017Post IPO$42.5M
- Aug 2014Post IPO$2.6M
- Feb 2014Post IPO$20M
Investors
Orbimed, Kitara Capital, Nylim-jb Asset Management, IFC, Strides Pharma Science, Acorus Capital
Tech stack
Animate.CssBootstrapContact Form 7Font AwesomeGodaddyGoogle Font Api
#5
Public · Hyderabad, Telangana · founded 1978 · 4321 employees$208.6Mraised▾
Public · Hyderabad, Telangana · founded 1978 · 4321 employees
Manufacturer of generic injectable drug. It focus on meeting diverse injectables needs with a stable supply of products. It have established a portfolio of injectables products across various therapeutic segments and delivery systems and are present in sterile injectables, oncology and ophthalmics with a focus on complex injectables.
Fliar Intelligence Index™ 57how this company ranks against its industry peers
Market
top 23%Fin. health
top 27%Moat
top 29%Funding
top 30%Talent
top 38%News
top 42%Market: 4,321 employees (top 2% of Biopharma Outsourcing) · Revenue ~$690M · ~3% of tracked Biopharma Outsourcing revenue (1485 cos, FY2025)
Fin. health: Revenue ~$690M (FY2022) · Net margin 17.8% · Revenue +0% YoY
Moat: Top 1% by revenue among 1485 tracked Biopharma Outsourcing companies · Editorial + unicorn rating 1/10 · IP moat: 14 patents
Audience (LinkedIn): 110k LinkedIn followers — 12.8% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Accounting & Tax Operations
Activity (LinkedIn): 1 awards announced in 12 mo
Founders & team
Investors
KKR, Gland Celsus Bio Chemicals, Punarvasu Bio-tech, Questarlaboratory, Satabisha Agro, Odin Discretionary Trust
Tech stack
Apache Http ServerBootstrapFont AwesomeGodaddyGoogle AnalyticsGoogle Tag Manager
#6
Series B · Hyderabad, Telangana · founded 2019 · 67 employees$13.4Mraised▾
Series B · Hyderabad, Telangana · founded 2019 · 67 employees
Contract manufacturer of bio-therapeutics and vaccines
Fliar Intelligence Index™ 50how this company ranks against its industry peers
Growth
top 30%Talent
top 38%Moat
top 46%Fin. health
top 50%Funding
bottom 46%Tech
bottom 46%Growth: Headcount 46 → 67 (+46%) across vintages · Web rank 50,000,000 → 10,000,000 YoY
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Moat: Top 30% by revenue among 1485 tracked Biopharma Outsourcing companies · Editorial + unicorn rating 1/10
Audience (LinkedIn): 11k LinkedIn followers
Activity (LinkedIn): 1 partnerships (incl. HandEdge BioOps Consulting LLC) announced in 12 mo
Funding rounds
- Dec 2021Series B$13.4M
Founders & team
Investors
Piramal Pharma Solutions, Piramal Group
Tech stack
BootstrapGoogle CloudGoogle Cloud CdnGsapHstsHttp/3
#7
Series A · Hyderabad, Telangana · founded 2023$2.1Mraised▾
Series A · Hyderabad, Telangana · founded 2023
Contract research and development offering drugs development services. The company specializes in providing robust drug discovery and medicinal chemistry services. It offers a range of services in the pre clinical development, toxicology, formulation advancement, analytical evaluation, infrastructure and support.
Fliar Intelligence Index™ 14how this company ranks against its industry peers
Growth
top 45%Talent
top 45%Tech
top 46%Funding
bottom 34%Global
bottom 29%Moat
bottom 27%Talent: 2 named leaders on record
Tech: 33 technologies across 3/8 capability areas · Cloud: Cloudflare · Security: Http/3, Recaptcha
Audience (LinkedIn): 7k LinkedIn followers
Hiring (LinkedIn): 7 hiring posts in 12 mo (public) · momentum +7 · hiring: Research Scientist / Senior Research Scientist, Clinical Research Coordinator
Funding rounds
- Aug 2023Series A$2.1M
Founders & team
Investors
Vessella
Tech stack
CloudflareCloudflare Browser InsightsContact Form 7Core-JsElementorEssential Addons For Elementor
#8
Public · Hyderabad, Telangana · founded 1984 · 1865 employees$26.8Mraised▾
Public · Hyderabad, Telangana · founded 1984 · 1865 employees
Neuland Laboratories is a leading manufacturer of active pharmaceutical ingredients (APIs), with two facilities, and customers in more than 85 countries. In addition to the manufacturing of APIs, Neuland provides customers with Contract research, contract manufacturing of generic APIs. The company's manufacturing facilities are approved by US FDA, TGA, EDQM and German Health Authorities. Neuland Labs also offers chemistry related services for the synthesis of library compounds to supply NCEs and intermediates at various clinical stages and commercially. The company claims to have over 700+ customers and to have filed over 45+ USDMFs and 400+ DMFs from health authorities from Europe, Canada, Japan, Korea and Australia. Neuland Labs also offers peptide manufacturing facilities solid phase peptide synthesis, solution phase methods, segment condensation and ligation techniques for peptides with amino acids ranging from 5 to 120.
Fliar Intelligence Index™ 82how this company ranks against its industry peers
Fin. health
top 15%Innovation
top 20%Product
top 21%Market
top 30%Tech
top 32%Moat
top 34%Fin. health: Revenue ~$216M (FY2018) · Net margin 17.6% · Revenue 8.1x total funding
Innovation: 7 product lines
Product: 7 distinct product lines · 2 published apps (3.8k installs) · Company stage: Public
Audience (LinkedIn): 96k LinkedIn followers — 11.2% of this cohort's audience
Activity (LinkedIn): 1 product launches · 1 partnerships (incl. Neuland) announced in 12 mo
Funding rounds
- May 2018Post IPO$18.4M
- Dec 2012Post IPO$8.4M
Founders & team
Investors
Evolvence, InvAscent, India Capital Growth
Tech stack
AddtoanyAddtoany Share ButtonsAmazon S3Amazon SesAmazon Web ServicesApache Http Server
#9
Series A · Hyderabad, Telangana · founded 2005 · 762 employees$16.8Mraised▾
Series A · Hyderabad, Telangana · founded 2005 · 762 employees
Company offering contract development services for small molecules
LinkedIn Pulse recent public activity · Jul 2026
Audience: 31k LinkedIn followers — 3.6% of this cohort's audience
Funding rounds
- Mar 2017Series A$9.2M
- Jan 2011Series A$5.1M
- Dec 2007Seed$2.5M
Founders & team
Investors
Mafatlal Industries, Mackertich Consultancy, Pearl Lane Coinvest, Zephyr Peacock, Zephyr Management, InvAscent
Tech stack
BootstrapCloudflareCloudflare Bot ManagementContact Form 7Core-JsGodaddy
#10
Seed · Hyderabad, Telangana · founded 2008 · 143 employees$2.7Mraised▾
Seed · Hyderabad, Telangana · founded 2008 · 143 employees
Chemveda is a company offering a range of services which include medicinal chemistry, library synthesis, custom synthesis, process chemistry, pre-formulation services, formulation services, pegylation, medical writing, and clinical research services. The company also offers collaborative drug services.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 14k LinkedIn followers
Hiring: 1 hiring post in 12 mo (public) · hiring: Research Chemist/Research Associate, Development Chemistry Designation
Activity: 2 expansions announced in 12 mo
Funding rounds
- May 2022Seed$1.1M
- Nov 2021Seed$1.4M
- Sep 2011Grant (prize money)$78.8K
Investors
Pasidi Greenlands, United States Department of Agriculture, BIRAC
Tech stack
AosApache Http ServerBootstrapCdnjsCloudflareCloudflare Bot Management
#11
Deadpooled · Hyderabad, Telangana · founded 1985$24.3Mraised▾
Deadpooled · Hyderabad, Telangana · founded 1985
CDMO focused on manufacturing of peptides
Funding rounds
- May 2007Post IPO$24.3M
Founders & team
Investors
Saffron Capital, BIRAC
#12
Seed · Hyderabad, Telangana · founded 2021$280.1Kraised▾
Seed · Hyderabad, Telangana · founded 2021
Technology platform that provides end-to-end scientific research solutions to the scientific community. It aims to help the scientific community translate their research ideas and findings into a communication ready format to reach audience.
Funding rounds
- Jan 2024Seed$30.1K
- Jan 2024Grant (prize money)—
- 2021Angel$250K
Founders & team
Investors
DLabs, Ministry of Electronics & Information Technology
Tech stack
Google AnalyticsGoogle Font ApiHostingerHttp/3LitespeedPwa
Funding & investor landscape
$699Mtotal disclosed funding
27companies funded
57disclosed rounds
0rounds last 90 days
Most active investors
Evolvence2 rounds
Sequoia Capital2 rounds
Ventureast2 rounds
Notable founders
Kamal P
Deputy General Manager · Aragen
Apurba Bhattacharya
Associate Director-HR · Aragen
Prathima Kanumuri
· Sai Life Sciences
Krishna Kanumuri
CEO & MD · Sai Life Sciences
Haribabu Bodepudi
Co-Founder & CEO · Viyash
Ravi Penmetsa
Co-Founder · Gland Pharma
Srinivas Sadu
Executive Chairman and CEO · Gland Pharma
Nirav Desai
Co-Founder · Yapanbio
Atin Tomar
Co-Founder & CEO · Yapanbio
Raghava Kethri
Co-Founder & CEO · Aryastha
Pradip Majumder
Co-Founder · Aryastha
Davuluri Rao
Vice Chairman of the Board and CEO · Neuland
Prism market signals · India · country-scoped Prism corpus, 274,226 docs
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time falling
Funding & growth over time
funding flat · growth rising
RESEARCH FROM Hyderabad · institutions
What Hyderabad researches in biotechnology
Osmania University, University of Hyderabad, and IIT Hyderabad lead Hyderabad's biotechnology research, focusing on RNA interference and phytochemicals, with a cautiously optimistic tone.
27 papersstance +0.2725% breakthrough35% concern
local research themes
RNA Interference and Gene DeliveryPhytochemicals and Medicinal PlantsDiverse Scientific Research Studiesvaccines and immunoinformatics approachesMedicinal Plants and NeuroprotectionPharmaceutical Quality and Counterfeiting
top institutions
- Osmania University11
- University of Hyderabad7
- Indian Institute of Technology Hyderabad6
- Birla Institute of Technology and Science - Hyderabad Campus2
- Jawaharlal Nehru Technological University, Hyderabad1
PATENT MOMENTUM · Hyderabad
Who's building biotechnology IP in Hyderabad
Bharat Biotech leads Hyderabad's biotechnology patents with 271, and filings show a broadly rising trend since 2014, though activity has fluctuated without sustained acceleration recently.
691 patents38 companiespeak 82/yr
filing momentum (YoY)
top patenters
- Bharat Biotech271Hyderabad
- Biological E129Hyderabad
- Dr. Reddy’s Laboratories56Hyderabad
- Indian Immunologicals27Hyderabad
- Revelations Biotech26Hyderabad
- PopVax20Hyderabad
- Telluris Biotech India19Hyderabad
- Sanzyme Biologics18Hyderabad
Common questions
How many Biopharma Outsourcing companies are there in Hyderabad, India?
Radar tracks 259 indexable Biopharma Outsourcing companies headquartered in Hyderabad, India, India, that meet our profile-completeness bar.
What is the total funding raised by Biopharma Outsourcing companies in Hyderabad, India?
The Biopharma Outsourcing companies in Hyderabad, India on this list have raised a combined $699M in disclosed equity funding across 27 funded companies.
Which is the highest-funded Biopharma Outsourcing company in Hyderabad, India?
Gland Pharma is the highest-funded Biopharma Outsourcing company in Hyderabad, India, with $208.6M in disclosed equity funding.
How many Biopharma Outsourcing companies in Hyderabad, India are funded?
27 of the 259 Biopharma Outsourcing companies in Hyderabad, India on this list have disclosed at least one equity funding round.
How many Biopharma Outsourcing unicorns are there in Hyderabad, India?
None of the Biopharma Outsourcing companies in Hyderabad, India on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Hyderabad, India Biopharma Outsourcing companies?
The most active investors in Hyderabad, India Biopharma Outsourcing companies on this list include BIRAC, IKP Knowledge Park, AIC-CCMB, InvAscent, Department of Biotechnology.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.